XNAS · EQ
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Equillium, Inc. Common Stock

Equillium, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.48
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
EQ
Equillium, Inc. Common Stock
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

85/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EQ moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EQ catalysts
About Equillium, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
14
Country
US

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.48
Last session
Day high
$2.48
Last session
Day low
$2.48
Last session
Previous close
$2.48
52W high
$3.20
-22.50% from high
52W low
$0.8400
69% of range
Market cap
$149.6M
Beta
1.49
Shares out
63.4M
Avg volume
640.2K
VWAP
$2.48
Last session
Price history computed in-house
1W
+11.21%
1M
-4.25%
3M
+20.39%
1Y
+85.07%
YTD
+60.00%
SMA 50 $2.64 · below
SMA 200 $1.91 · above
52W position 69%

EQ overview

Veridion Score
85
Daily close · 2026-08-17
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EQ.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EQ Form 4 filings
Public disclosures

Congress activity in EQ

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EQ in the cached public ledger.

Federal contracts

EQ contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EQ in this window.
Lobbying spend

EQ lobbying filings, year to date.

Registered lobbying filings matched to Equillium, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EQ in this window.
Loading news for EQ
Analyst ratings
Sovereign unlock shows live analyst consensus for EQ.
Options
Sovereign unlock shows live options positioning for EQ.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.